Literature DB >> 21818689

The impact of motor and non motor symptoms on health state values in newly diagnosed idiopathic Parkinson's disease.

James Shearer1, Colin Green, Carl E Counsell, John P Zajicek.   

Abstract

The aim of the study was to estimate health state utility values in newly diagnosed idiopathic Parkinson's disease (PD) for use in the assessment of health-related quality-of-life (HRQL), and in the estimation of quality-adjusted life-years (QALYs). Data from 162 patients enrolled in a community-based incidence study of PD were used to estimate health state utility values. Self-report data from the EQ-5D, a generic measure of HRQL, were used to derive preference-based health state utility values. The impact of motor and non motor symptoms, and other clinical and demographic factors, on the derived EQ-5D health state values was examined in univariate and multivariate analyses. The mean health state utility value for recently diagnosed PD patients was estimated at 0.65 ± 0.27. Significant reductions in health state values were attributable to pain (-0.18), motor functioning (-0.16), depression (-0.12), and insomnia (-0.11). Depression had its greatest impact (-0.19) in patients in the less severe stages of PD (i.e. Hoehn Yahr stages ≤2.5). This study shows, through the presentation of QALY values, that there is scope to achieve significant health gains in newly diagnosed idiopathic PD patients via improved management of pain, depression and insomnia, alongside the treatment of primary motor symptoms.

Entities:  

Mesh:

Year:  2011        PMID: 21818689     DOI: 10.1007/s00415-011-6202-y

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  30 in total

1.  What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them?

Authors:  David A Gallagher; Andrew J Lees; Anette Schrag
Journal:  Mov Disord       Date:  2010-11-15       Impact factor: 10.338

2.  Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations.

Authors:  Christopher G Goetz; Werner Poewe; Olivier Rascol; Cristina Sampaio; Glenn T Stebbins; Carl Counsell; Nir Giladi; Robert G Holloway; Charity G Moore; Gregor K Wenning; Melvin D Yahr; Lisa Seidl
Journal:  Mov Disord       Date:  2004-09       Impact factor: 10.338

Review 3.  EuroQol: the current state of play.

Authors:  R Brooks
Journal:  Health Policy       Date:  1996-07       Impact factor: 2.980

Review 4.  The economics of comparative effectiveness research.

Authors:  E Ray Dorsey; David O Meltzer
Journal:  Neurology       Date:  2010-08-10       Impact factor: 9.910

5.  The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study.

Authors:  Kallol Ray Chaudhuri; Pablo Martinez-Martin; Richard G Brown; Kapil Sethi; Fabrizio Stocchi; Per Odin; William Ondo; Kazuo Abe; Graeme Macphee; Doug Macmahon; Paolo Barone; Martin Rabey; Alison Forbes; Kieran Breen; Susanne Tluk; Yogini Naidu; Warren Olanow; Adrian J Williams; Sue Thomas; David Rye; Yoshio Tsuboi; Annette Hand; Anthony H V Schapira
Journal:  Mov Disord       Date:  2007-10-15       Impact factor: 10.338

6.  Pilot study of the incidence and prognosis of degenerative Parkinsonian disorders in Aberdeen, United Kingdom: methods and preliminary results.

Authors:  Kate S M Taylor; Carl E Counsell; Clare E Harris; Joanna C Gordon; W Cairns S Smith
Journal:  Mov Disord       Date:  2006-07       Impact factor: 10.338

7.  How does Parkinson's disease affect quality of life? A comparison with quality of life in the general population.

Authors:  A Schrag; M Jahanshahi; N Quinn
Journal:  Mov Disord       Date:  2000-11       Impact factor: 10.338

8.  Assessing health-related quality of life in patients with Parkinson's disease in a prospective longitudinal study.

Authors:  M Reuther; E A Spottke; J Klotsche; O Riedel; H Peter; K Berger; O Athen; R Köhne-Volland; R C Dodel
Journal:  Parkinsonism Relat Disord       Date:  2006-10-19       Impact factor: 4.891

9.  Predictors and course of health-related quality of life in Parkinson's disease.

Authors:  Elin Bjelland Forsaa; Jan Petter Larsen; Tore Wentzel-Larsen; Karen Herlofson; Guido Alves
Journal:  Mov Disord       Date:  2008-07-30       Impact factor: 10.338

10.  Health related quality of life in early Parkinson's disease: impact of motor and non-motor symptoms, results from Chinese levodopa exposed cohort.

Authors:  Zhaohui Qin; Liyan Zhang; Fei Sun; Xianghua Fang; Cheryl Meng; Caroline Tanner; Piu Chan
Journal:  Parkinsonism Relat Disord       Date:  2009-06-23       Impact factor: 4.891

View more
  24 in total

1.  Using Canadian Primary Care Sentinel Surveillance Network data to examine depression in patients with a diagnosis of Parkinson disease: a retrospective cohort study.

Authors:  Kimberly Rose P Singian; Morgan Price; Vicky Bungay; Sabrina T Wong
Journal:  CMAJ Open       Date:  2016-08-08

2.  The heterogeneity of non-motor symptoms of Parkinson's disease.

Authors:  Ning Zhang; Weiguo Liu; Min Ye; Alexander D Cohen; Yingdong Zhang
Journal:  Neurol Sci       Date:  2014-11-07       Impact factor: 3.307

Review 3.  A systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease from 2005 to 2015.

Authors:  Lama M Chahine; Amy W Amara; Aleksandar Videnovic
Journal:  Sleep Med Rev       Date:  2016-08-31       Impact factor: 11.609

Review 4.  Parkinson disease in the elderly adult.

Authors:  Allison W Willis
Journal:  Mo Med       Date:  2013 Sep-Oct

5.  Association of Motor and Nonmotor Symptoms With Health-Related Quality of Life in a Large Online Cohort of People With Parkinson Disease.

Authors:  Meredith A Bock; Ethan G Brown; Li Zhang; Caroline Tanner
Journal:  Neurology       Date:  2022-04-13       Impact factor: 11.800

6.  Gastrointestinal Dysfunction Impact on Life Quality in a Cohort of Russian Patients with Parkinson's Disease I-III H&Y Stage.

Authors:  A A Pilipovich; O V Vorob'eva; S A Makarov; N N Shindryaeva; Yu D Vorob'eva
Journal:  Parkinsons Dis       Date:  2022-04-28

7.  Patient Utilities in Health States Based on Hoehn and Yahr and Off-Time in Parkinson's Disease: A Swedish Register-Based Study in 1823 Observations.

Authors:  Jenny M Norlin; Klas Kellerborg; Per Odin
Journal:  Pharmacoeconomics       Date:  2021-07-07       Impact factor: 4.981

8.  A method for measuring time spent in bradykinesia and dyskinesia in people with Parkinson's disease using an ambulatory monitor.

Authors:  Hamid Khodakarami; Navid Shokouhi; Malcolm Horne
Journal:  J Neuroeng Rehabil       Date:  2021-07-16       Impact factor: 4.262

Review 9.  Parkinson's disease related pain: a review of recent findings.

Authors:  A Truini; M Frontoni; G Cruccu
Journal:  J Neurol       Date:  2012-11-23       Impact factor: 4.849

Review 10.  Transcranial direct current stimulation (tDCS) for idiopathic Parkinson's disease.

Authors:  Bernhard Elsner; Joachim Kugler; Marcus Pohl; Jan Mehrholz
Journal:  Cochrane Database Syst Rev       Date:  2016-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.